SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies
- 2 October 2021
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 102 (1) , 115565
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Covid-19 Breakthrough Infections in Vaccinated Health Care WorkersNew England Journal of Medicine, 2021
- Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in FranceThe Lancet Regional Health - Europe, 2021
- Novel SARS-CoV-2 variants: the pandemics within the pandemicClinical Microbiology and Infection, 2021
- SARS-CoV-2 Infection after Vaccination in Health Care Workers in CaliforniaNew England Journal of Medicine, 2021
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingNew England Journal of Medicine, 2021
- Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December 2020–March 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodiesNature Medicine, 2021
- Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular ScreeningClinical Infectious Diseases, 2021